Invited Commentary: Human Papillomavirus Infection and Risk of Cervical Precancer-Using the Right Methods to Answer the Right Questions

被引:3
|
作者
Franco, Eduardo L. [1 ]
Tota, Joseph
机构
[1] McGill Univ, Div Canc Epidemiol, Dept Epidemiol & Biostat, Montreal, PQ H2W 1S6, Canada
关键词
cytology; measurement error; misclassification; papillomavirus infections; uterine cervical neoplasms; vaginal smears; INTRAEPITHELIAL NEOPLASIA; RANDOMIZED-TRIAL; CANCER; BEHAVIOR; TYPE-16; WOMEN; DNA;
D O I
10.1093/aje/kwp392
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Epidemiologists are well aware of the negative consequences of measurement error in exposure and outcome variables to their ability to detect putative causal associations. However, empirical proof that remedying the misclassification problem improves estimates of epidemiologic effect is seldom examined in detail. Of all areas in cancer epidemiology, perhaps the best example of the consequences of misclassification and of the steps taken to circumvent them was the pursuit, beginning in the mid-1980s, of the human papillomavirus (HPV) infection-cervical cancer association. The stakes were high: Had the wrong conclusions been reached epidemiologists would have been led astray in the search for competing hypotheses for the sexually transmissible agent causing cervical cancer or in ascribing to HPV infection a mere ancillary role among many lifestyle, hormonal, and environmental factors. The article by Castle et al. in this issue of the Journal (Am J Epidemiol. 2010;171(2):155-163) provides a detailed account of the joint influences of improved HPV and cervical precancer measurements in gradually unveiling the strong magnitude of the underlying association between viral exposure and cervical lesion risk. In this commentary, the authors extend the findings of Castle et al. by providing additional empirical evidence in support of their arguments.
引用
收藏
页码:164 / 168
页数:5
相关论文
共 8 条
  • [1] Genital Tract HIV RNA Levels and Their Associations With Human Papillomavirus Infection and Risk of Cervical Precancer
    Ghartey, Jeny
    Kovacs, Andrea
    Burk, Robert D.
    Massad, L. Stewart
    Minkoff, Howard
    Xie, Xianhong
    D'souza, Gypsyamber
    Xue, Xiaonan
    Watts, D. Heather
    Levine, Alexandra M.
    Einstein, Mark H.
    Colie, Christine
    Anastos, Kathryn
    Eltoum, Isam-Eldin
    Herold, Betsy C.
    Palefsky, Joel M.
    Strickler, Howard D.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 66 (03) : 316 - 323
  • [2] Invited commentary: Is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening?
    Castle, Philip E.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 168 (02) : 138 - 144
  • [3] Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment
    Kreimer, Aimee R.
    Schiffman, Mark
    Herrero, Rolando
    Hildesheim, Allan
    Gonzalez, Paula
    Burk, Robert D.
    Porras, Carolina
    Sherman, Mark E.
    Demuth, Franklin
    Cheung, Li
    Bratti, Concepcion
    Cecilia Rodriguez, Ana
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (01) : 211 - 218
  • [4] Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer =15 years later
    Inturrisi, Federica
    Bogaards, Johannes A.
    Siebers, Albert G.
    Meijer, Chris J. L. M.
    Heideman, Danielle A. M.
    Berkhof, Johannes
    TUMOUR VIRUS RESEARCH, 2022, 14
  • [5] Determining the prevalence of high-risk human papillomavirus infection using a novel cervical precancer screening approach in incarcerated women at the Nsawam Medium Security Prison, Ghana
    Acheampong, Lawrence Kofi
    Effah, Kofi
    Amuah, Joseph Emmanuel
    Tekpor, Ethel
    Wormenor, Mawusi Mawusi
    Gedzah, Isaac
    Kemawor, Seyram
    Kachana, Ateba Cynthia
    Danso, Peace Afi
    Essel, Nana Owusu Mensah
    Asomaning, Mabel
    Agyiri, Dominic
    Akakpo, Patrcik Kafui
    ECANCERMEDICALSCIENCE, 2021, 15
  • [6] Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection
    Shah, KV
    Solomon, L
    Daniel, R
    Cohn, S
    Vlahov, D
    JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (02) : 517 - 519
  • [7] PREVALENCE OF HUMAN PAPILLOMAVIRUS (HPV) INFECTION IN BASQUE COUNTRY WOMEN USING SLOT-BLOT HYBRIDIZATION - A SURVEY OF WOMEN AT LOW-RISK OF DEVELOPING CERVICAL-CANCER
    MUGICAVANHERCKENRODE, C
    MALCOLM, ADB
    COLEMAN, DV
    INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (04) : 581 - 586
  • [8] Assessment of High-Risk Human Papillomavirus Infections Using Clinician- and Self-Collected Cervical Sampling Methods in Rural Women from Far Western Nepal
    Johnson, Derek C.
    Bhatta, Madhav P.
    Smith, Jennifer S.
    Kempf, Mirjam-Colette
    Broker, Thomas R.
    Vermund, Sten H.
    Chamot, Eric
    Aryal, Shilu
    Lhaki, Pema
    Shrestha, Sadeep
    PLOS ONE, 2014, 9 (06):